01-01-1998 | ORIGINAL ARTICLE
Transforming growth factor β , (TGFβ) secreted by immunogenic ex vivo human carcinoma cells, counteracts the activation and inhibits the function of autologous cytotoxic lymphocytes. Pretreatment with interferon γ and tumor necrosis factor α reduces the production of active TGFβ
Published in: Cancer Immunology, Immunotherapy | Issue 6/1998
Login to get access